Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2025-12-25 @ 3:20 AM
NCT ID: NCT05416905
Eligibility Criteria: Inclusion Criteria: 1. Adult subject (male or female, 18-75 years); 2. Diagnosed with idiopathic craniofacial dystonia for more than 1 year, including at least one of the eye and oromandibular region. Cervical dystonia may be present; 3. Treated with oral drugs or botulinum toxin injections, but with no satisfactory curative effect; 4. Normal cognitive function with MMSE score ≥ 24; 5. Informed consent signed. Exclusion Criteria: 1. Only cervical dystonia, or combined with dystonia in other parts of the body other than the cervical region; 2. Diagnosed with other neuropsychiatric diseases(Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, etc.); 3. History of brain surgery; 4. Severe depression with HRSD score ≥ 35; 5. Contraindications to neurosurgery(cerebral infarction, hydrocephalus, cerebral atrophy, sequelae of cerebrovascular disease, etc); 6. Contraindications to CT or MRI scanning(claustrophobia, etc); 7. pregnant or breastfeeding female, or has positive pregnancy test prior to randomization; 8. Contraindications to general anesthesia (severe arrhythmia, severe anemia, abnormal liver and kidney function, etc.); 9. Expected lifetime \< 12 months; 10. Currently receiving an investigational drug or device; 11. Other circumstances that the investigator considers unsuitable to participate in this study or that may pose a significant risk to the patient (inability to understand or comply with research procedures and follow-up, etc.).
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 75 Years
Study: NCT05416905
Study Brief:
Protocol Section: NCT05416905